Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03129620 · ClinicalTrials.gov registry record
Pharmacokinetics of Ampicillin in Neonates With Moderate to Severe Hypoxic-Ischemic Encephalopathy
A clinical trial of Hypothermia, sponsored by Drexel University.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT03129620: Completed study of Hypothermia, sponsored by Drexel University.
NCT03129620 is a study of Hypothermia that has completed, run by Drexel University. The registered enrollment target is 14 participants, below the 47-participant average among 9 other Hypothermia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03129620, a study of Hypothermia, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Controlled Hypothermia has become the standard of care for neonates with moderate to severe HIE. Ampicillin and aminoglycosides are drugs that are universally used for the treatment of suspected neonatal sepsis, which may or may not be responsible for the etiology of HIE. Currently, medication dosage regimens are not altered in the setting of CH. A better understanding of the effects of our interventions on this unique population may help us tailor our therapy to the specific circumstances of the patient
Primary Outcome
Ampicillin concentration at 3 time points to determine clearance and serum levels
Conditions Studied
Study Locations (1)
Pennsylvania
- St Christopher's Hospital for children - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-04 |
What the finished NCT03129620 record still lists
NCT03129620 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 47-participant average among 9 other Hypothermia trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Hypothermia appearing as the primary indexed condition, and to 0 interventions.
NCT03129620 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03129620 about?
NCT03129620 is a clinical study titled "Pharmacokinetics of Ampicillin in Neonates With Moderate to Severe Hypoxic-Ischemic Encephalopathy". Controlled Hypothermia has become the standard of care for neonates with moderate to severe HIE. Ampicillin and aminoglycosides are drugs that are universally used for the treatment of suspected neonatal sepsis, which may or may not be responsible for the etiology of HIE. Currently, medication dosag...
What is the current status of trial NCT03129620?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2013-03. Estimated completion is 2016-04.
What conditions does trial NCT03129620 study?
This clinical trial studies the following conditions: Hypothermia.
Who is sponsoring clinical trial NCT03129620?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03129620 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothermia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03129620's enrollment target sits among peer trials
14 10th of 9 the lowest of 9 other Hypothermia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypothermia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Blood Warming in Preterm Infants to Decrease Hypothermia
RECRUITING · NA
-
Pharmacologic Induction of Tolerance for Hypoxia & Hypothermia
ACTIVE NOT RECRUITING
-
Neonatal Warming to Prevent Hypothermia
COMPLETED · NA
-
Thermal Compression Device for Maintenance of Perioperative Normothermia
COMPLETED · NA
-
Hypothermia to Treat Severe Brain Injury
COMPLETED · NA
-
Comparison of Bi-environmental Conditions During Occupational Related Activity
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia